{"data":[{"accessionNo":"0001390202-26-000019","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Janaka Sheehan Maduraperuma","reportingCik":null,"personType":"HC,IN","sharesOwned":4300888,"percentOfClass":5.16,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001390202-26-000019","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Benjamin Alexander Smith","reportingCik":null,"personType":"HC,IN","sharesOwned":4300888,"percentOfClass":5.16,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001390202-26-000019","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Laurion Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4300888,"percentOfClass":5.16,"filedAt":"2026-11-03","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006818","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Global Investments LP","reportingCik":null,"personType":"IA,PN","sharesOwned":20441948,"percentOfClass":16.4,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006818","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Long Biased Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":20441948,"percentOfClass":16.4,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006818","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Long Biased GP LLC","reportingCik":null,"personType":"OO","sharesOwned":20441948,"percentOfClass":16.4,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006818","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Craig D. Gordon","reportingCik":null,"personType":"HC,IN","sharesOwned":20441948,"percentOfClass":16.4,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-26-113597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6448907,"percentOfClass":5.42,"filedAt":"2026-10-05","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-26-113597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital Partners LP","reportingCik":null,"personType":"PN","sharesOwned":6448907,"percentOfClass":5.42,"filedAt":"2026-10-05","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-26-113597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6448907,"percentOfClass":5.42,"filedAt":"2026-10-05","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-26-113597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Coastlands Capital LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":6448907,"percentOfClass":5.42,"filedAt":"2026-10-05","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-26-113597","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Matthew D. Perry","reportingCik":null,"personType":"HC,IN","sharesOwned":6448907,"percentOfClass":5.42,"filedAt":"2026-10-05","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006608","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Global Investments LP","reportingCik":null,"personType":"IA,PN","sharesOwned":27988714,"percentOfClass":17.5,"filedAt":"2026-10-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006608","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Long Biased Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":27988714,"percentOfClass":17.5,"filedAt":"2026-10-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006608","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"GordonMD Long Biased GP LLC","reportingCik":null,"personType":"OO","sharesOwned":27988714,"percentOfClass":17.5,"filedAt":"2026-10-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-006608","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-10-01","reportingPerson":"Craig D. Gordon","reportingCik":null,"personType":"HC,IN","sharesOwned":27988714,"percentOfClass":17.5,"filedAt":"2026-10-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":8336902,"percentOfClass":9.99,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":8336902,"percentOfClass":9.99,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":8336902,"percentOfClass":9.99,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":7695734,"percentOfClass":9.2,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":4611887,"percentOfClass":5.5,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4611887,"percentOfClass":5.5,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3083847,"percentOfClass":3.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":3083847,"percentOfClass":3.7,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":518280,"percentOfClass":0.6,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000921895-26-001796","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-07-02","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":518280,"percentOfClass":0.6,"filedAt":"2026-07-10","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-004255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"GordonMD Long Biased Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":10024909,"percentOfClass":12.1,"filedAt":"2026-07-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-004255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"GordonMD Global Investments LP","reportingCik":null,"personType":"IA,PN","sharesOwned":10024909,"percentOfClass":12.1,"filedAt":"2026-07-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-004255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"GordonMD Long Biased GP LLC","reportingCik":null,"personType":"OO","sharesOwned":10024909,"percentOfClass":12.1,"filedAt":"2026-07-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-26-004255","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":"747324101","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Craig D. Gordon","reportingCik":null,"personType":"HC,IN","sharesOwned":10024909,"percentOfClass":12.1,"filedAt":"2026-07-02","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001390202-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Laurion Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":4796479,"percentOfClass":7.72,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001390202-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Benjamin Alexander Smith","reportingCik":null,"personType":"HC,IN","sharesOwned":4796479,"percentOfClass":7.72,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001390202-26-000002","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Janaka Sheehan Maduraperuma","reportingCik":null,"personType":"HC,IN","sharesOwned":4796479,"percentOfClass":7.72,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-25-099264","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":818134,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-25-099264","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":818134,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0001104659-25-099264","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":818134,"percentOfClass":1.3,"filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-25-005781","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-14","reportingPerson":"GordonMD Global Investments LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3834740,"percentOfClass":6.2,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-25-005781","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-14","reportingPerson":"GordonMD Long Biased Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":3834740,"percentOfClass":6.2,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-25-005781","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-14","reportingPerson":"GordonMD Long Biased GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3834740,"percentOfClass":6.2,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"},{"accessionNo":"0000919574-25-005781","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001782223","issuerName":"Pyxis Oncology, Inc.","ticker":"PYXS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-07-14","reportingPerson":"Craig D. Gordon","reportingCik":null,"personType":"HC,IN","sharesOwned":3834740,"percentOfClass":6.2,"filedAt":"2025-09-23","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs"}],"updatedAt":"2026-11-03T16:50:32.897Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/pyxs","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}